61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A EPS (earnings per share) 2002–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Genmab A/S ADS's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 0.55 USD, down 15.4% on the same quarter a year before. Genmab A/S ADS's diluted earnings per share over the last twelve months were 1.17 USD, down 83.8% on the twelve months before. In fiscal year 2025 they were 1.54 USD, down 87.3% on the year before.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 1.17 | -83.82% | 1.19 |
| FY2025 | 31 Dec 2025 | 1.54 | -87.31% | 1.55 |
| FY2024 | 31 Dec 2024 | 12.14 | +83.94% | 12.14 |
| FY2023 | 31 Dec 2023 | 6.60 | -20.10% | 6.60 |
| FY2022 | 31 Dec 2022 | 8.26 | +84.37% | 8.34 |
| FY2021 | 31 Dec 2021 | 4.48 | -37.95% | 4.52 |
| FY2020 | 31 Dec 2020 | 7.22 | +112.35% | 7.30 |
| FY2019 | 31 Dec 2019 | 3.40 | +43.46% | 3.44 |
| FY2018 | 31 Dec 2018 | 2.37 | +33.15% | 2.40 |
| FY2017 | 31 Dec 2017 | 1.78 | -7.29% | 1.81 |
| FY2016 | 31 Dec 2016 | 1.92 | +52.38% | 1.98 |
| FY2015 | 31 Dec 2015 | 1.26 | +137.74% | 1.31 |
| FY2014 | 31 Dec 2014 | 0.53 | +140.91% | 0.54 |
| FY2013 | 31 Dec 2013 | 0.22 | — | 0.22 |
| FY2012 | 31 Dec 2012 | -1.06 | — | -1.06 |
| FY2011 | 31 Dec 2011 | -1.33 | — | -1.33 |
| FY2010 | 31 Dec 2010 | -0.72 | — | -0.72 |
| FY2009 | 31 Dec 2009 | -2.25 | — | -2.25 |
| FY2008 | 31 Dec 2008 | -2.16 | — | -2.16 |
| FY2007 | 31 Dec 2007 | -0.87 | — | -0.87 |
| FY2006 | 31 Dec 2006 | -1.13 | — | -1.13 |
| FY2005 | 31 Dec 2005 | -1.26 | — | -1.26 |
| FY2004 | 31 Dec 2004 | -1.57 | — | -1.57 |
| FY2003 | 31 Dec 2003 | -1.43 | — | -1.43 |
| FY2002 | 31 Dec 2002 | -2.15 | — | -2.15 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.55 | -15.38% | 0.56 |
| Q2 FY2026 | 30 Jun 2026 | 0.49 | -9.26% | 0.49 |
| Q1 FY2026 | 31 Mar 2026 | 0.08 | +84.44% | 0.09 |
| Q4 FY2025 | 31 Dec 2025 | 0.05 | -99.23% | 0.05 |
| Q3 FY2025 | 30 Sept 2025 | 0.65 | -66.67% | 0.65 |
| Q2 FY2025 | 30 Jun 2025 | 0.54 | +74.19% | 0.54 |
| Q1 FY2025 | 31 Mar 2025 | 0.05 | -97.77% | 0.05 |
| Q4 FY2024 | 31 Dec 2024 | 5.99 | +517.53% | 5.99 |
| Q3 FY2024 | 30 Sept 2024 | 1.95 | -39.63% | 1.95 |
| Q2 FY2024 | 30 Jun 2024 | 0.31 | -84.95% | 0.32 |
| Q1 FY2024 | 31 Mar 2024 | 2.02 | +531.25% | 2.03 |
| Q4 FY2023 | 31 Dec 2023 | 0.97 | +24.36% | 0.98 |
| Q3 FY2023 | 30 Sept 2023 | 3.23 | -17.60% | 3.26 |
| Q2 FY2023 | 30 Jun 2023 | 2.06 | -28.22% | 2.08 |
| Q1 FY2023 | 31 Mar 2023 | 0.32 | -54.93% | 0.32 |
| Q4 FY2022 | 31 Dec 2022 | 0.78 | -27.78% | 0.79 |
| Q3 FY2022 | 30 Sept 2022 | 3.92 | +190.37% | 3.96 |
| Q2 FY2022 | 30 Jun 2022 | 2.87 | +523.91% | 2.89 |
| Q1 FY2022 | 31 Mar 2022 | 0.71 | -57.23% | 0.71 |
| Q4 FY2021 | 31 Dec 2021 | 1.08 | +22.73% | 1.10 |
| Q3 FY2021 | 30 Sept 2021 | 1.35 | +68.75% | 1.36 |
| Q2 FY2021 | 30 Jun 2021 | 0.46 | -91.05% | 0.47 |
| Q1 FY2021 | 31 Mar 2021 | 1.66 | +304.88% | 1.68 |
| Q4 FY2020 | 31 Dec 2020 | 0.88 | -61.74% | 0.88 |
| Q3 FY2020 | 30 Sept 2020 | 0.80 | -3.61% | 0.81 |
| Q2 FY2020 | 30 Jun 2020 | 5.14 | +3,571.43% | 5.19 |
| Q1 FY2020 | 31 Mar 2020 | 0.41 | +241.67% | 0.41 |
| Q4 FY2019 | 31 Dec 2019 | 2.30 | +71.64% | 2.33 |
| Q3 FY2019 | 30 Sept 2019 | 0.83 | +186.21% | 0.84 |
| Q2 FY2019 | 30 Jun 2019 | 0.14 | -66.67% | 0.14 |
| Q1 FY2019 | 31 Mar 2019 | 0.12 | -62.50% | 0.12 |
| Q4 FY2018 | 31 Dec 2018 | 1.34 | +6.35% | 1.36 |
| Q3 FY2018 | 30 Sept 2018 | 0.29 | — | 0.29 |
| Q2 FY2018 | 30 Jun 2018 | 0.42 | -16.00% | 0.43 |
| Q1 FY2018 | 31 Mar 2018 | 0.32 | +1,130.77% | 0.33 |
| Q4 FY2017 | 31 Dec 2017 | 1.26 | -7.35% | 1.29 |
| Q3 FY2017 | 30 Sept 2017 | -0.01 | -102.90% | -0.01 |
| Q2 FY2017 | 30 Jun 2017 | 0.50 | +85.19% | 0.51 |
| Q1 FY2017 | 31 Mar 2017 | 0.03 | — | 0.03 |
| Q4 FY2016 | 31 Dec 2016 | 1.36 | +106.06% | 1.40 |
| Q3 FY2016 | 30 Sept 2016 | 0.31 | +34.78% | 0.32 |
| Q2 FY2016 | 30 Jun 2016 | 0.27 | +900.00% | 0.28 |
| Q1 FY2016 | 31 Mar 2016 | -0.02 | -105.28% | -0.02 |
| Q4 FY2015 | 31 Dec 2015 | 0.66 | +450.00% | 0.68 |
| Q3 FY2015 | 30 Sept 2015 | 0.23 | -17.86% | 0.24 |
| Q2 FY2015 | 30 Jun 2015 | 0.03 | — | 0.03 |
| Q1 FY2015 | 31 Mar 2015 | 0.36 | +100.00% | 0.38 |
| Q4 FY2014 | 31 Dec 2014 | 0.12 | +9.09% | 0.12 |
| Q3 FY2014 | 30 Sept 2014 | 0.28 | +2,700.00% | 0.28 |
| Q2 FY2014 | 30 Jun 2014 | -0.05 | — | -0.05 |
| Q1 FY2014 | 31 Mar 2014 | 0.18 | +28.57% | 0.18 |
| Q4 FY2013 | 31 Dec 2013 | 0.11 | — | 0.12 |
| Q3 FY2013 | 30 Sept 2013 | 0.01 | — | 0.01 |
| Q2 FY2013 | 30 Jun 2013 | -0.05 | — | -0.05 |
| Q1 FY2013 | 31 Mar 2013 | 0.14 | — | 0.14 |
| Q4 FY2012 | 31 Dec 2012 | -0.75 | — | -0.75 |
| Q3 FY2012 | 30 Sept 2012 | -0.12 | — | -0.12 |
| Q2 FY2012 | 30 Jun 2012 | -0.00 | — | -0.00 |
| Q1 FY2012 | 31 Mar 2012 | -0.16 | — | -0.16 |
| Q4 FY2011 | 31 Dec 2011 | -0.10 | — | -0.10 |
| Q3 FY2011 | 30 Sept 2011 | -0.80 | — | -0.80 |
| Q2 FY2011 | 30 Jun 2011 | -0.18 | — | -0.18 |
| Q1 FY2011 | 31 Mar 2011 | -0.25 | — | -0.25 |
| Q4 FY2010 | 31 Dec 2010 | -0.19 | — | -0.19 |
| Q3 FY2010 | 30 Sept 2010 | -0.04 | — | -0.04 |
| Q2 FY2010 | 30 Jun 2010 | -0.20 | — | -0.20 |
| Q1 FY2010 | 31 Mar 2010 | -0.29 | — | -0.29 |
| Q4 FY2009 | 31 Dec 2009 | -1.35 | — | -1.35 |
| Q3 FY2009 | 30 Sept 2009 | -0.20 | — | -0.20 |
| Q2 FY2009 | 30 Jun 2009 | -0.25 | — | -0.25 |
| Q1 FY2009 | 31 Mar 2009 | -0.44 | — | -0.44 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Genmab A's EPS
Source: Financial Modeling Prep